Add BrightSurf on Google Email

George Institute for Global Health


Intensive blood pressure-lowering cut recurrent stroke risk by around 38% after brain haemorrhage

A meta-analysis of four randomised controlled trials involving 2,944 adults with intracerebral haemorrhage found that intensive blood pressure-lowering reduced recurrent stroke risk by 38%. The treatment strategy was consistent across all studies, with no observed increase in serious adverse events.

SourceGeorge Institute for Global Health·JournalThe Lancet Neurology·TypeMeta-analysis·DateAug 12, 2026

Low-dose triple-pill cut risk of recurrent stroke by about 40%, global trial shows

A global trial involving 1,670 patients with intracerebral haemorrhage found that treatment with a single pill combination of three low-dose blood pressure medicines reduced the risk of another stroke by 39%. The study showed significant benefits in reducing major cardiovascular events and improving blood pressure control.

SourceGeorge Institute for Global Health·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 22, 2026

Comprehensive analysis supports routine use of metabolic drug for people with all levels of kidney function

A comprehensive analysis of 70,000 participants across 10 trials found that SGLT2 inhibitors reduced the risk of chronic kidney disease (CKD) progression by 38% and slowed eGFR decline by 51%. The treatment was beneficial for all levels of kidney function and albuminuria levels, particularly in reducing hospitalizations.

SourceGeorge Institute for Global Health·JournalJAMA·TypeMeta-analysis·DateNov 7, 2025

Popular diabetes and obesity drugs also protect kidneys, study shows

Researchers found that GLP-1 receptor agonists reduced the risk of kidney failure by 16% and worsening of kidney function by 22%. The combined reduction in risk was 19%, showing a clear benefit on kidney protection. This study expands current knowledge about this class of drugs, highlighting their role in treating patients with chronic...

SourceGeorge Institute for Global Health·JournalThe Lancet Diabetes & Endocrinology·TypeMeta-analysis·DateNov 25, 2024

Combining popular diabetes drugs offers complementary heart and kidney benefits

Researchers found that combining sodium glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists reduces the risk of major adverse cardiovascular events and chronic kidney disease progression by 11% and 33%, respectively. The study suggests using this combination to further improve outcomes in patients with typ...

SourceGeorge Institute for Global Health·JournalThe Lancet Diabetes & Endocrinology·TypeMeta-analysis·DateJul 8, 2024

Simple food swaps could cut greenhouse gas emissions from household groceries by a quarter

A new study reveals that switching to environmentally friendly food alternatives can significantly reduce greenhouse gas emissions from household groceries. The analysis found that making like-for-like product swaps within sub-categories of foods could lead to emission reductions of up to 26% or 71%.

SourceGeorge Institute for Global Health·JournalNature Food·TypeData/statistical analysis·DateMay 28, 2024

Very early blood pressure control confers both benefits and harms in acute stroke

A new study found that very early blood pressure lowering treatment can improve outcomes for patients with intracerebral hemorrhage, but worsen outcomes for those with ischemic stroke. Rapid diagnosis of the type of stroke is crucial in harnessing the benefits of this treatment.

SourceGeorge Institute for Global Health·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMay 16, 2024

Choice of intravenous fluid therapy could improve survival in critically ill patients

A new meta-analysis found that intravenous fluid therapy using balanced solutions can reduce the risk of in-hospital death in critically ill patients by four percent. Balanced solutions are more closely matched to human blood chemistry than commonly used saline, and may be associated with lower mortality rates.

SourceGeorge Institute for Global Health·JournalThe Lancet Respiratory Medicine·TypeMeta-analysis·DateNov 30, 2023

Large stroke trial finds intensive blood pressure lowering after clot removal worsens recovery

A large stroke trial found that intensive blood pressure lowering after clot removal compromises the return of blood flow to the affected area, leading to more brain tissue deterioration and major disability. The study suggests that this increasingly common treatment strategy should be avoided in clinical practice.

SourceGeorge Institute for Global Health·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateOct 28, 2022

Controlling gut flora can reduce mortality in critically ill patients on life support

A randomized clinical trial found that applying topical antibiotics to the upper digestive tract can improve survival rates in mechanically ventilated intensive care patients. The study, published in JAMA, also showed a significant reduction in new hospital-acquired infections.

SourceGeorge Institute for Global Health·JournalJournal of the American Medical Association·TypeRandomized controlled/clinical trial·DateOct 26, 2022

Time to shift research focus from ‘bikini medicine’ to what is really ailing women

A new study found that women's health research is disproportionately focused on reproductive years, particularly pregnancy, leaving few articles on major causes of illness and death. Non-communicable diseases, such as cancer and cardiovascular disease, are poorly covered in women's health publications.

SourceGeorge Institute for Global Health·JournalJournal of Women s Health·TypeSystematic review·DateMar 29, 2022

Keep taking the tablets - ‘big data’ provides clues on how to help prevent repeat heart attacks

Research found that individuals who have previously taken cholesterol- or blood pressure-lowering medications before a heart attack were less likely to adhere to these medications afterwards. Despite the proven benefits, fewer than one-third of patients continued taking their prescribed tablets for over a year after hospitalization.

SourceGeorge Institute for Global Health·JournalFrontiers in Pharmacology·TypeObservational study·DateMar 7, 2022

Australian study set to guide the treatment of critically ill patients worldwide

A large clinical trial involving over 5,000 patients found that commonly used saline solution is as effective at keeping people alive and their organs functioning as more expensive balanced solutions. The study's results provide greater certainty about the safety and benefits of saline solution for treatment.

SourceGeorge Institute for Global Health·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJan 18, 2022

Sticking to low-fat dairy may not be the only heart healthy option, study shows

A new study has found that consuming more dairy fat may actually be beneficial for heart health, challenging traditional dietary guidelines. The research analyzed data from over 43,000 people and found that those with higher intakes of dairy fat had a lower risk of cardiovascular disease compared to those with low intakes.

SourceGeorge Institute for Global Health·JournalPLOS Medicine·TypeSystematic review·DateSep 21, 2021

Salt substitution -- an effective way to reduce blood pressure in rural India

A new study by The George Institute for Global Health found that replacing regular salt with a reduced-sodium, added-potassium salt substitute significantly lowered systolic blood pressure in rural Indian hypertensive patients. The intervention was shown to be an effective and low-cost way to control blood pressure in these communities.

SourceGeorge Institute for Global Health·JournalAmerican Journal of Clinical Nutrition·DateMar 30, 2021

Failing to see the forest for the trees may prevent better cardiovascular outcomes

A new study from The George Institute for Global Health found that countries are wasting resources by treating only one aspect of cardiovascular disease, rather than looking at the big picture. The researchers discovered a higher risk of CVD in lower educated and non-employed people, as well as an underuse of medicines in those at high...

SourceGeorge Institute for Global Health·JournalPLOS Medicine·DateMar 4, 2021

Time to re-define sex-specific symptoms of acute coronary syndrome, say researchers

A new study published in Journal of the American Heart Association has found that women and men experience overlapping and distinct symptoms when presenting with acute coronary syndrome. Women are more likely to present with fatigue, pain between the shoulder blades, and shortness of breath, while both sexes often experience chest pain.

SourceGeorge Institute for Global Health·JournalJournal of the American Heart Association·DateMay 4, 2020